Medicare rewrites TAVR coverage rules in a potentially important access catalyst for Edwards Lifesciences
CMS has modernized Medicare coverage for transcatheter aortic valve replacement, ending evidence-development requirements for symptomatic severe aortic stenosis while creating a pathway for certain asymptomatic patients.
